![]() |
市场调查报告书
商品编码
1787982
全球叶酸市场预测(至 2032 年):按等级、产地、形式、通路、用途和地区划分Folic Acid Market Forecasts to 2032 - Global Analysis By Grade, Source, Form, Distribution Channel, Application, and By Geography |
根据 Stratistics MRC 的数据,全球叶酸市场规模预计在 2025 年达到 11.5 亿美元,到 2032 年将达到 15.7 亿美元,预测期内的复合年增长率为 4.6%。
叶酸是维生素B9的合成形式,用于膳食补充剂和食品强化。它在DNA合成、细胞分裂和红血球生成中发挥重要作用。通常建议孕妇补充叶酸,以帮助预防发育中胎儿的神经管缺陷。叶酸是一种水溶性维生素,对整体代谢功能至关重要,并被广泛纳入减少分娩相关併发症的公共卫生策略中。
根据美国疾病管制与预防美国(CDC)的数据,受孕前每天服用400微克叶酸,可使神经管缺陷的风险降低约80%。
增加膳食补充剂的消费
膳食补充剂消费的成长持续推动叶酸市场的发展。随着消费者高度重视预防性医疗保健和主动健康,人们越来越倾向于选择含叶酸的强化食品、膳食补充剂和功能性产品。此外,持续的公共卫生宣传活动也提高了人们对叶酸在预防神经管缺陷和支持整体健康方面作用的认识,尤其是在孕妇和存在叶酸缺乏风险的人群中。注重健康的生活方式与食品科学技术创新的融合预计将进一步刺激市场需求。
开发中地区公众意识有限
儘管全球都在努力,但发展中地区对叶酸健康益处的认识不足仍然是限制其发展的一大因素。许多地区对叶酸缺乏的后果(例如贫血和发育迟缓)仍有认知差距,导致强化叶酸产品和补充剂的摄取量较低。此外,政府主导的营养计划和医疗基础设施的差异也对普及教育和有效市场渗透构成挑战。新兴经济体持续缺乏叶酸认知,这继续限制叶酸市场成长潜力的充分发挥。
拓展至机能性食品及饮料
随着製造商不断创新,将叶酸添加到零嘴零食、饮料、谷物和乳製品中,消费者将能够无缝补充每日摄取量。此外,协调一致的政府措施和食品强化法规为市场参与企业创造了充足的空间,使其能够丰富产品组合併开发新产品,以满足不断变化的消费者偏好。人们越来越注重更健康的饮食习惯,注重便利性和营养强化,预计将进一步推动市场发展。
替代维生素和营养素
随着消费者日益青睐种类繁多的综合维他命和替代性微量营养素补充剂,叶酸在宣传活动和产品配方方面都面临着竞争。消费者越来越关注整体营养,而非单一营养素,这可能会分散人们对叶酸特定产品的注意力和支出。此外,针对类似健康状况的替代成分有效性的研究也日渐深入,这可能会威胁叶酸在某些消费群体中的主导地位。
新冠疫情提高了人们对预防保健和免疫系统支持的认识,对叶酸市场产生了积极影响。随着消费者在危机期间更加重视健康,对含叶酸补充剂的需求显着增加。此外,人们越来越意识到微量营养素在对抗疾病和支持整体健康方面的重要性,这也导致了强化叶酸产品的消费增加。这种健康意识的增强可能会增强市场的持续成长,并在疫情结束后产生持久的影响。
预计医药级细分市场在预测期内将占最大份额
预计在预测期内,药用级叶酸将占据最大的市场份额,这得益于处方药和孕产妇补充剂中药用级叶酸的广泛应用,而这些产品对产品的纯度、效力和合规性至关重要。此细分市场受益于营养缺乏症盛行率的上升、育龄妇女补充剂摄取量的增加以及医疗保健专业人士的推荐。此外,市场占有率人口的不断增长使人们面临更高的营养缺乏相关併发症的风险,这也推动了对药用级叶酸解决方案的强劲需求。
预计在预测期内,线上部分将以最高的复合年增长率成长。
预计线上市场将在预测期内实现最高成长率,这主要得益于电商平台的便利性和可近性,使消费者和小买家能够轻鬆购买叶酸补充剂。疫情加速了数位健康通路的普及,消费者对非接触式购物的偏好日益增长,这进一步刺激了线上销售。此外,线上平台产品日益多样化和价格竞争力的提升也促进了强劲成长。
预计北美将在预测期内占据最大的市场占有率,这得益于其成熟的医疗基础设施、对孕产妇营养重要性的高度认识以及完善的政府强化法规。强化食品和膳食补充剂的普及,以及主要製药和膳食补充剂公司在研发方面的大量投入,进一步巩固了北美的主导。此外,确保全民叶酸摄取的监管标准以及庞大的老化人口规模,将继续支撑该地区庞大的市场需求。
预计亚太地区将在预测期内实现最高的复合年增长率。该地区市场的快速扩张得益于可支配收入的提高、健康意识的增强以及政府为消除营养不良而采取的积极倡议。中国和印度等国家正透过广泛的公共卫生计划和针对妇女和儿童的免费补充剂供应计划来推动这一增长。此外,不断壮大的中阶和持续加强的医疗基础设施预计将维持该地区叶酸需求的高速成长轨迹。
According to Stratistics MRC, the Global Folic Acid Market is accounted for $1.15 billion in 2025 and is expected to reach $1.57 billion by 2032 growing at a CAGR of 4.6% during the forecast period. Folic acid is a synthetic form of vitamin B9 used in dietary supplements and food fortification. It plays a vital role in DNA synthesis, cell division, and red blood cell production. Commonly recommended for pregnant women, it helps prevent neural tube defects in developing fetuses. As a water-soluble vitamin, folic acid is crucial for overall metabolic function and is widely included in public health strategies to reduce birth-related complications.
According and data from the U.S. Centers for Disease Control and Prevention (CDC), daily intake of 400 micrograms of folic acid before conception can reduce the risk of neural tube defects by approximately 80%.
Increasing nutraceutical consumption
Rising consumption of nutraceuticals continues to propel the folic acid market. As consumers place higher value on preventative healthcare and proactive wellness, there is a notable shift toward fortified foods, dietary supplements, and functional products containing folic acid. Moreover, sustained public health campaigns have raised awareness about the role of folic acid in preventing neural tube defects and supporting overall health, particularly for pregnant women and populations at risk for deficiencies. The convergence of health-conscious lifestyles and innovation in food science is expected to further accelerate market demand.
Limited public awareness in developing regions
Despite global efforts, limited awareness about the health benefits of folic acid remains a prominent constraint in developing regions. In many areas, knowledge gaps persist regarding the consequences of folic acid deficiency, such as anemia and developmental disorders, resulting in underutilization of fortified products and supplements. Additionally, variations in government-led nutrition initiatives and healthcare infrastructure pose challenges to widespread education and effective market penetration. This persistent lack of awareness in emerging economies continues to restrict the full realization of folic acid market growth potential.
Expansion into functional foods and beverages
As manufacturers innovate to incorporate folic acid in snacks, drinks, cereals, and dairy products, consumers can supplement their daily intake seamlessly. Furthermore, collaborative government initiatives and mandates for food fortification create ample scope for market participants to diversify portfolios and develop new products tailored to evolving consumer preferences. The ongoing trend of health-oriented diets, focused on convenience and enhanced nutrition, is expected to fuel the market.
Substitute vitamins and nutrients
With consumers' access to a broad range of multivitamins and alternative micronutrient supplements, folic acid faces competition in both awareness campaigns and product formulations. An increasing focus on holistic nutritional intake, rather than targeting single nutrients, could divert attention and expenditures away from folic acid-specific products. Moreover, evolving research on the efficacy of alternative ingredients in addressing similar health conditions may challenge the primacy of folic acid in certain consumer segments.
The Covid-19 pandemic positively influenced the folic acid market by fostering greater awareness of preventative healthcare and immune system support. As consumers became increasingly concerned about maintaining health during the crisis, the demand for supplements, including folic acid, experienced a marked uptick. Additionally, heightened recognition of the importance of micronutrients in combating illness and supporting general well-being led to increased consumption of folic acid-fortified products. This heightened health consciousness is likely to have a lasting impact, reinforcing sustained market growth even beyond the pandemic period.
The pharmaceutical grade segment is expected to be the largest during the forecast period
The pharmaceutical grade segment is expected to account for the largest market share during the forecast period, attributed to the widespread usage of pharmaceutical-grade folic acid in prescription medications and prenatal supplements, where product purity, efficacy, and compliance with regulatory standards are paramount. The segment benefits from a growing prevalence of deficiency disorders, increasing rates of supplementation among women of childbearing age, and recommendations from healthcare professionals. Additionally, the expanding geriatric population and their elevated risk of deficiency-related complications reinforce strong demand for pharmaceutical-grade folic acid solutions.
The online segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the online segment is predicted to witness the highest growth rate, primarily driven by the convenience and accessibility provided by e-commerce platforms, enabling consumers and small-scale buyers to source folic acid supplements with minimal effort. The proliferation of digital health channels and an increasing consumer preference for contactless shopping, accelerated by the pandemic, have further stimulated online sales. Additionally, growing product variety and competitive pricing on online platforms contribute to the robust growth.
During the forecast period, the North America region is expected to hold the largest market share, supported by mature healthcare infrastructure, high awareness regarding the importance of prenatal nutrition, and firmly established governmental fortification mandates. Widespread access to fortified foods and dietary supplements, combined with significant R&D investments by leading pharmaceutical and nutraceutical firms, further underpins North America's leadership. Moreover, regulatory standards ensuring population-wide exposure to folic acid and a large aging demographic continue to support substantial market demand in the region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. The region's rapid market expansion is propelled by rising disposable income, escalating health awareness, and substantial government initiatives aimed at eradicating nutrient deficiencies. Countries such as China and India are driving this growth with widespread public health programs and free supplementation initiatives targeting women and children. Additionally, an expanding middle class and continual enhancement of healthcare infrastructure are expected to maintain the region's high growth trajectory for folic acid demand.
Key players in the market
Some of the key players in Folic Acid Market include BASF SE, DSM-Firmenich AG, Zydus Lifesciences Limited, Medicamen Biotech Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Emcure Pharmaceuticals Ltd., Balchem Corporation, Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd., Merck KGaA, Lonza Group AG, Parchem Fine & Specialty Chemicals, Xinfa Pharmaceutical Co., Ltd., Nantong Changhai Food Additive Co. Ltd., Hebei Jiheng Group Pharmaceutical Co. Ltd., Gnosis by Lesaffre, Vertellus Holdings LLC, and Shengda Pharmaceutical Co., Ltd.
In May 2025, Emcure Pharmaceuticals has approved the incorporation of a wholly-owned subsidiary named Emcure Generics Private Limited, based in Pune, Maharashtra. The new entity will focus on manufacturing, promoting, selling, and distributing pharmaceutical and related products.
In November 2023, Buhler and dsm-firmenich join forces to advance efforts to combat hidden hunger in Nigeria. In collaboration with Buhler, dsm-firmenich, a leading innovator in health and provider of nutritional solutions, is committed to combatting hidden hunger through the provision of nutritional solutions such as fortified rice. "Nigeria's malnutrition is growing steadily due to factors such as suboptimal diets, economic conditions, and environmental change; it poses a great health risk.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.